European equities traded in the US as American depositary receipts were trending higher late Monday morning, rising 0.60% to 1,888.94 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical companies Cellectis (CLLS) and DBV Technologies (DBVT), which advanced 6% and 2.7% respectively. Also rising were internet advertising firm Criteo (CRTO) and biotech company Evaxion (EVAX), which increased 3.6% and 6.3% respectively.
The decliners from continental Europe were led by telecommunications operator Nokia (NOK) and medical device maker EDAP TMS (FOCL), which fell 2.8% and 1% respectively. Anheuser-Busch InBev(BUD), which was off 1.2%.
The gainers from the UK were led by biopharmaceutical company NuCana (NCNA) and software firm Endava (DAVA), which rose 3.2% and 2.5% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and oil and gas company BP (BP), which were up 1.4% and 1.1% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Akari Therapeutics (AKTX), which lost 4.9% and 2.1% respectively. They were followed by biotech firmTrinity Biotech (TRIB), which dropped 0.3%.
Biopharmaceutical company Amarin (AMRN) was modestly higher.
Comments